Market Introduction
APAC continent comprises several developing economies such as India, China, Japan, South Korea, Australia, among others. These emerging countries are witnessing an upsurge in industrialization and urbanization activities, offering ample opportunities for the key market players in the Medical Polyoxymethylene market. The Medical Polyoxymethylene industry in the countries of APAC has experienced a considerable shift over the years. The massive growth of the Asia-Pacific region market is due to the rising investment in advanced healthcare facilities and infrastructure in emerging economies, such as India and China. The robust manufacturing base of the engineered plastics in China, Japan, and India, high demand for polyoxymethylene in various application bases are expected to augment regional market growth. Furthermore, favorable policies implemented by the government of India and Make in India, are expected to create sufficient growth opportunities for the healthcare industry, which, in turn, is expected to increase the consumption of medical polyoxymethylene in the region. Also, emanation of applications in tissue engineering is the major factor driving the growth of the APAC medical polyoxymethylene market.
The COVID-19 is anticipated to cause a significant economic loss in Asia Pacific. The consequence and impact are likely to worsen with the spread of the virus. The governments of various Asia Pacific countries imposed lockdown in early 2020 to restrict the spread of the virus, which, in turn, negatively impacted the Medical Polyoxymethylene market revenue. The ongoing COVID-19 pandemic has significantly impacted the medical polyoxymethylene industry's growth prospects. Due to the sudden closure of national and international borders, the outbreak has distorted operational efficiency and disrupted value chains, resulting in revenue loss and damage. Raw material supply has suffered as a result of the disrupted value chain. However, as economies plan to restart their operations, demand for medical polyoxymethylene is expected to increase in the coming months. However, the emphasis on just-in-time production is another factor impeding the growth of the APAC medical polyoxymethylene market.
Market Overview and Dynamics
The medical polyoxymethylene market in APAC is expected to reach US$ 47,426.65 thousand by 2028 from US$ 34,330.62 thousand in 2020. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2028. Healthcare-associated infections (HCAI) or nosocomial infections are the infections associated with the equipment and devices, such as catheters or ventilators, used during medical procedures. Over the period, there has been rising prevalence of HCAI diseases, which has become a serious concern among various economies. HCAIs poses major health challenge in healthcare units and the conditions arising from HCAIs is the sixth leading cause of death in western nations and even higher in other developing economies.
Key Market Segments
The APAC medical polyoxymethylene market is segmented into application, and country. On the basis of application, the APAC medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical polyoxymethylene market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Ensinger; Inventro Polymers; Kolon Plastics; Korea Engineering Plastics Co., Ltd.; LG Chem; Mitsubishi Chemical Corporation; and Polyplastics Co., Ltd. among others.
Reasons to buy report
APAC Medical Polyoxymethylene Market Segmentation
APAC Medical Polyoxymethylene Market -By Application
APAC Medical Polyoxymethylene Market -By Country
APAC Medical Polyoxymethylene Market -Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 34,330.62 thousand |
| Market Size by 2028 | US$ 47,426.65 thousand |
| CAGR (2020 - 2028) | 4.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Application
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Medical Polyoxymethylene Market is valued at US$ 34,330.62 thousand in 2020, it is projected to reach US$ 47,426.65 thousand by 2028.
As per our report Asia Pacific Medical Polyoxymethylene Market, the market size is valued at US$ 34,330.62 thousand in 2020, projecting it to reach US$ 47,426.65 thousand by 2028. This translates to a CAGR of approximately 4.1% during the forecast period.
The Asia Pacific Medical Polyoxymethylene Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Polyoxymethylene Market report:
The Asia Pacific Medical Polyoxymethylene Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Polyoxymethylene Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Polyoxymethylene Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Medical Polyoxymethylene Market
